UY26992A1 - NEW COMPOSITIONS OF MEDICINES ON THE BASE OF ANTICHOLINERGIC AND CORTICOESTEROID AGENTS - Google Patents
NEW COMPOSITIONS OF MEDICINES ON THE BASE OF ANTICHOLINERGIC AND CORTICOESTEROID AGENTSInfo
- Publication number
- UY26992A1 UY26992A1 UY26992A UY26992A UY26992A1 UY 26992 A1 UY26992 A1 UY 26992A1 UY 26992 A UY26992 A UY 26992A UY 26992 A UY26992 A UY 26992A UY 26992 A1 UY26992 A1 UY 26992A1
- Authority
- UY
- Uruguay
- Prior art keywords
- anticholinergic
- agents
- corticoesteroid
- medicines
- base
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001078 anti-cholinergic effect Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 229960001334 corticosteroids Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Abstract
El presente invento se refiere a nuevas composiciones de medicamentos sobre la base de agentes anticolinérgicos y corticoesteroides, a procedimientos para su preparación así como a su utilización en la terapia de enfermedades de las vías respiratorias.The present invention relates to new compositions of medicaments based on anticholinergic agents and corticosteroids, procedures for their preparation as well as their use in the therapy of respiratory diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10054042 | 2000-10-31 | ||
DE10062712A DE10062712A1 (en) | 2000-12-15 | 2000-12-15 | New drug compositions based on anticholinergics and corticosteroids |
Publications (1)
Publication Number | Publication Date |
---|---|
UY26992A1 true UY26992A1 (en) | 2002-06-20 |
Family
ID=26007540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY26992A UY26992A1 (en) | 2000-10-31 | 2001-10-29 | NEW COMPOSITIONS OF MEDICINES ON THE BASE OF ANTICHOLINERGIC AND CORTICOESTEROID AGENTS |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1333830A2 (en) |
JP (1) | JP2004512359A (en) |
AU (1) | AU2002210575A1 (en) |
CA (2) | CA2436540C (en) |
MX (1) | MXPA03003751A (en) |
PE (1) | PE20020576A1 (en) |
UY (1) | UY26992A1 (en) |
WO (1) | WO2002036106A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7214687B2 (en) | 1999-07-14 | 2007-05-08 | Almirall Ag | Quinuclidine derivatives and medicinal compositions containing the same |
ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
US7244415B2 (en) | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
DE10214263A1 (en) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA suspension formulations containing an anticholinergic |
US7311894B2 (en) | 2002-03-28 | 2007-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations containing an anticholinergic |
US7084153B2 (en) | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
DE10216429A1 (en) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20040102469A1 (en) * | 2002-09-13 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for reducing the mortality rate |
PT1891974E (en) | 2004-05-31 | 2010-09-27 | Almirall Sa | Combinations comprising antimuscarinic agents and pde4 inhibitors |
ES2257152B1 (en) | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS. |
WO2006003078A1 (en) * | 2004-06-29 | 2006-01-12 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising steroids and an anticholinergic |
GB0523653D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
ES2298049B1 (en) | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO. |
JP2010519195A (en) | 2007-02-19 | 2010-06-03 | シプラ・リミテッド | Pharmaceutical composition |
EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
TR200909793A2 (en) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative. |
TR200909789A2 (en) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Dry powder combination containing tiotropium, budesonide and a chromoglycic acid derivative combination |
TR200909792A2 (en) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Dry powder combination containing tiotropium, corticosteroid and a combination of chromoglycic acid derivative |
US8834931B2 (en) | 2009-12-25 | 2014-09-16 | Mahmut Bilgic | Dry powder formulation containing tiotropium for inhalation |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
AU2021314977A1 (en) | 2020-07-31 | 2023-03-02 | Chemo Research, S.L. | Combination therapy for inhalation administration |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0504112A3 (en) * | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
DE19835346A1 (en) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Two-part capsule for pharmaceutical preparations for powder inhalers |
GB0009605D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medicaments |
GB0009592D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
GB0009606D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic combinations |
-
2001
- 2001-10-23 WO PCT/EP2001/012511 patent/WO2002036106A2/en active Application Filing
- 2001-10-23 EP EP01978463A patent/EP1333830A2/en not_active Ceased
- 2001-10-23 AU AU2002210575A patent/AU2002210575A1/en not_active Abandoned
- 2001-10-23 JP JP2002538918A patent/JP2004512359A/en active Pending
- 2001-10-23 CA CA002436540A patent/CA2436540C/en not_active Expired - Fee Related
- 2001-10-23 MX MXPA03003751A patent/MXPA03003751A/en active IP Right Grant
- 2001-10-23 CA CA2733294A patent/CA2733294C/en not_active Expired - Fee Related
- 2001-10-29 UY UY26992A patent/UY26992A1/en not_active Application Discontinuation
- 2001-10-29 PE PE2001001073A patent/PE20020576A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002036106A3 (en) | 2002-09-19 |
MXPA03003751A (en) | 2004-10-15 |
CA2436540A1 (en) | 2002-05-10 |
AU2002210575A1 (en) | 2002-05-15 |
PE20020576A1 (en) | 2002-08-09 |
EP1333830A2 (en) | 2003-08-13 |
JP2004512359A (en) | 2004-04-22 |
CA2733294A1 (en) | 2002-05-10 |
CA2733294C (en) | 2011-12-20 |
WO2002036106A2 (en) | 2002-05-10 |
CA2436540C (en) | 2008-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26992A1 (en) | NEW COMPOSITIONS OF MEDICINES ON THE BASE OF ANTICHOLINERGIC AND CORTICOESTEROID AGENTS | |
ECSP034571A (en) | NEW COMPOSITIONS OF MEDICINES BASED ON SALOTETOL SALTS AND TIOTROPIO SALTS | |
AR034213A1 (en) | COMPOSITIONS OF DRUGS ON THE BASE OF ANTI-POLINERGIC AGENTS AND INHIBITORS OF PDE-IV | |
UY26139A1 (en) | COMPOSITIONS OF MEDICINAL PRODUCTS BASED ON ANTICHOLINERGICALLY ACTIVE AND BETA-MIMETIC COMPOUNDS | |
UY28923A1 (en) | THERAPEUTIC COMPOUNDS: PYRIDINE AS A BASE STRUCTURE | |
UY27759A1 (en) | COMBINATIONS OF DRUGS CONTAINING HETEROCYCLIC COMPOUNDS AND A NEW ANTI-POLYNERGIC AGENT. | |
CO5640037A2 (en) | DERIVATIVES OF QUINAZOLINE FOR THE TREATMENT OF CANCER | |
HN2001000037A (en) | DERIVATIVES OF ETERES DE PIRAZOL AS ANTI-INFLAMMATORY / ANALGESIC AGENTS | |
UY27342A1 (en) | CRYSTAL ANTI-POLYNERGIC AGENT, PROCEDURE FOR ITS PREPARATION AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
UY30438A1 (en) | N-SUBSTITUTED DERIVATIVES OF 5-HALO-4- [2-RENT-1-SUBSTITUTES-1H-IMIDAZOL-5-IL] PIRIMIDIN-2-AMINA, COMPOSITIONS-PROCESSES FOR PREPARATION AND USES | |
HN1999000124A (en) | SUBSTITUTED PYRAZOLE DERIVATIVES. | |
BR0308429A (en) | Monocyclic Aroylpyridinones as Anti-Inflammatory Agents | |
UY28922A1 (en) | RECEIVER CB1 LINKS USEFUL IN THE TREATMENT OF PAIN AND / OR OTHER SYMPTOMS OR RELATED DISEASES; PHARMACEUTICAL COMPOUNDS AND THEIR PREPARATION. | |
UY27388A1 (en) | NEW COMPOUNDS | |
UY26957A1 (en) | NEW ANTI-POLYNERGIC AGENTS THAT CAN BE USED AS MEDICATIONS AS WELL AS PROCEDURE FOR PREPARATION | |
AR060019A1 (en) | PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER | |
UY27725A1 (en) | CRYSTALLINE MICRONIZED MATERIAL, PROCEDURE FOR ITS PREPARATION AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT. | |
PA8654701A1 (en) | REPLACED INDOLES, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE | |
CR9114A (en) | 2-ALCOXI-3,4,5-TRIHYDROXI-ALQUIMIDAS, ITS PREPARATION COMPOSITIONS THAT CONTAIN THEM AND ITS USE | |
UY29823A1 (en) | SUBSTITUTED DERIVATIVES OF 7-CHLORINE-3H-IMIDAZOL- (4,5-B) PIRIDINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THE PREPARATION OF THE SAME AND APPLICATIONS | |
UY28536A1 (en) | DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME. | |
BR0210912A (en) | Compounds and compositions as cathepsin inhibitors | |
BRPI0413129A (en) | inhalation medicines including betamimetics and anticholinergics | |
SE0102440D0 (en) | New compound | |
SE0401655D0 (en) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150513 |